Clinical Research Details

Back to List
Descriptive Information
Quality of life in patients receiving peptide receptor radionuclide therapy (PRRT) at AUBMC 

Sally Temraz
st29@aub.edu.lb

BIO-2018-0025
Ongoing

Clinical Research - Epidemiologic and Behavioral Studies  


No
Coordinators
Farah Nassar
fn17@aub.edu.lb
Extension: 5112
Conditions and Keywords
quality of life ,neuroendocrine tumors,peptide receptor radionuclide therapy
Quality of life of patients with neuroendocrine tumors and treated with peptide receptor radionuclide therapy
Study Design
Other: Describe in Detailed Description
N/A: Not Applicable
Observational Study
N/A: Not Applicable
N/A: Not Applicable
N/A: Not Applicable
Case-Only
Eligibility and IRB
Both
Min:
Max:
Yes
No

We aim to evaluate patients’ expectations about the impact of peptide receptor radionuclide therapy (PRRT) on their health related quality of life (HRQol) and their actual quality of life  QoL in patients with neuroendocrine tumors (NETs).. We will also be able to assess the quality of life in elderly patients, and those with multiple comorbidities (ECOG performance status at baseline between 0 to 2 ),when being treated with PRRT, as there are few studies evaluating the health related quality of life (HRQol) in these two subgroups.

 






Back to List